MSB 7.69% $1.19 mesoblast limited

MSB to dispute FDA finding in Type A meeting, page-227

  1. 5,481 Posts.
    lightbulb Created with Sketch. 8927
    I totally agree with what you are saying and those at MSB are likely to put as much 'indirect' pressure as possible on the FDA.

    But there is so much going on in the media right now... that this is unlikely to get the media attention & pressure we think it deserves.

    I'm crossing my fingers that we start to see more media coverage & pressure from other groups ... but those impacted by SR-aGVHD are small and their voice may very well be drowned out by the sea of noise caused by the pandemic & presidential election...
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.